查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
2023-2030 年全球乳腺病变定位市场
市场调查报告书
商品编码
1270935

2023-2030 年全球乳腺病变定位市场

Global Breast Lesion Localization Market 2023-2030
出版日期: | 出版商: Orion Market Research | 英文 | 商品交期: 2-3个工作天内

价格

到 2022 年，全球乳腺病变定位市场规模将达到 4.8 亿美元，预测期内（2023-2030 年）的复合年增长率为 7.8%，到 2030 年将达到 8 亿美元。预计将达到 12 美元百万。 由于全球乳腺癌患病率上升，预计全球乳腺病变定位市场在预测期内将出现显着增长。 及早发现可触及和不可触及的乳房病变中的恶性肿瘤，可以有效及时地治疗各种乳房异常。 全世界每年诊断出的乳腺癌中有三分之一是微观的，并且随着筛查计划变得更加广泛和更先进的方式（例如 MRI 检测临床上可能的病变），这一水平正在上升。 MRI 是一种安全、准确、非手术的诊断可疑乳腺影像异常的方法，对于製定正确的决策（包括制定治疗计划）至关重要。 预计乳腺癌患病率的增加将提高女性对这种疾病的认识，并有助于市场的增长。 此外，市场上越来越多的筛选和成像技术也有望推动市场增长。

细分市场展望

全球乳腺病变定位市场根据类型和应用进行细分。 根据类型，市场分为电线定位、放射性同位素定位、磁定位、电磁定位和其他定位。 此外，根据应用，市场分为乳房活检、乳房保护（肿块切除术）等。 其中，由于全球女性乳腺癌患者人数不断增加等因素，保乳手术预计在预测期内将占据很大的市场份额。

乳腺病变定位的全球市场预计将由线材定位细分市场主导。

在乳腺病变定位系统市场，导线定位部分预计在预测期内将出现显着增长。 这是由于乳腺癌患者增加、技术先进产品增加以及产品发布增加等因素造成的。 此外，基于导线的定位所提供的优势，例如比其他乳腺病变定位技术更便宜、更准确和更有效，预计将增加在乳腺癌治疗中的采用。 预计该因素也将对该细分市场的增长产生积极影响。

区域展望

全球乳腺病变定位市场分为北美（美国、加拿大）、欧洲（意大利、西班牙、德国、法国等）、亚太地区（印度、中国、日本、韩国等）、其他地区World of the World. 它根据区域进一步细分，包括世界区域（中东和非洲，拉丁美洲）。 我们还可以应要求提供特定地区或国家层面的市场分析。 其中，亚太地区正在进行扩大产品组合、业务多元化、降低成本、提高用户满意度、提高乳腺病变定位方法可靠性等战略举措，预计将占很大份额。中等市场增长。

北美有望主导全球乳腺病变定位市场

预计在预测期内，北美将占据显着的市场份额。 越来越多的乳腺癌患者、强大的医疗基础设施以及对乳腺癌的认识不断提高等因素正在推动乳腺病变定位市场的增长。 预计乳腺癌患者的增加将增加对治疗乳腺癌的诊断和外科手术的需求，从而促进乳腺病变定位市场的增长。 此外，该地区不断增加的产品批准预计将增加市场上本地化设备的可用性，从而推动预测期内的市场增长。

市场参与者展望：

全球乳腺病变定位市场的主要参与者包括 Argon Medical Devices、Matek Medical Devices Technology Industry and Trade Inc.、Sterylab S.R.L.、Medax Medical Devices 等。 市场参与者通过采用併购、合作伙伴关係、合作、融资和新产品发布等各种战略来保持市场竞争力，为市场增长做出了重大贡献。 例如，2022 年 7 月，Merit Medical System 在一项上市后观察研究中宣布了首位註册患者，以证明其无线雷达引导立体定向系统 SCOUT 在标记乳腺肿瘤、活检部位和淋巴结方面的优势。

内容

第 1 章报告概述

  • 分析行业现状和发展前景
  • 研究方法和工具
  • 市场细分
    • 按细分
    • 按地区

第 2 章市场概述和洞察

  • 调查范围
  • 分析师观点和当前市场趋势
    • 主要发现
    • 建议
    • 结论

第三章竞争格局

  • 主要公司分析
    • 概览
    • 财务分析
    • SWOT 分析
    • 近期趋势
  • 关键策略分析

第四章市场细分

  • 全球乳腺病变定位市场：按类型分类
    • 电线定位
    • 放射性同位素定位
    • 磁性定位
    • 电磁定位
    • 其他本地化
  • 全球乳腺病变定位市场：按预期用途分类
    • 乳房活检
    • 保乳手术（乳房肿瘤切除术）
    • 其他

第五章区域分析

  • 北美
    • 美国
    • 加拿大
  • 欧洲
    • 英国
    • 德国
    • 意大利
    • 西班牙
    • 法国
    • 其他欧洲
  • 亚太地区
    • 中国
    • 印度
    • 日本
    • 韩国
    • 其他亚太地区
  • 世界其他地区

第六章公司简介

  • Argon Medical Devices
  • Becton, Dickinson and Co.
  • Biomedical S.R.L
  • Biopsybell S.R.L.
  • C.R. Bard, Inc.
  • CP Medical
  • Devicor Medical Products Inc.
  • Endomagnetics Ltd.
  • Hologic Inc.
  • IsoAid
  • Leica Biosystems Nussloch GmbH
  • Matek Medical Devices Technology Industry and Trade Inc.
  • MDL SRL
  • Medax Medical Devices
  • Merit Medical Systems, Inc.
  • Mermaid Medical A/S
  • Molli Surgical Inc.
  • Ranfac Corp.
  • Sirius Medical Systems B.V.
  • Sterylab S.R.L.
  • SurgicEye GmbH
  • Tsunami Medical S.R.L.
  • Vigeo S.R.L.
Product Code: OMR2023832

The global breast lesion localization market size was valued at $480 million in 2022, and is projected to reach $812 million by 2030, registering a CAGR of 7.8% during the forecast period (2023-2030). The global breast lesion localization market is expected to witness significant growth during the forecast period due to rising prevalence of breast cancer across the globe. Early detection of the malignancy of palpable and non-palpable breast lesions can result in effective and timely treatment of various breast abnormalities. One-third of breast cancers diagnosed each year globally are subtle, and this level rises as screening programs become more prevalent and more advanced modalities such as MRI detect more clinically potential lesions. It is a safe and accurate non-surgical method for diagnosing suspicious abnormal findings in breast images and is essential for proper decision making, including treatment planning. The rising incidence of breast cancer is creating awareness about the disease among women which is expected to contribute to the growth of the market. Further, the rise in the number of screening and imaging techniques in the market is also expected to propel the market growth.

Segmental Outlook:

The global breast lesion localization market is segmented based on the type and usage. Based on the type, the market is segmented into wire localization, radioisotope localization, magnetic localization, electromagnetic localization, and other localization. Based on the usage, the market is further sub-segmented into breast biopsy, breast conservation (lumpectomy), and others. Among the usage, the breast conservation is expected to hold considerable share in the market over the forecast period owing to factors such as the rising number of breast cancer among the women globally.

The Wire Localization Sub-Segment is anticipated to Hold Prominent Share in the Global Breast Lesion Localization Market

The wire localization segment is expected to witness significant growth in the breast lesion localization systems market over the forecast period owing to factors such as the rising prevalence of breast cancer among the population, growing technologically advanced products, and rising product launches. The advantages offered by the wire localization method, such as being less expensive, more accurate, and more effective than other breast lesion localization techniques, are also expected to increase its adoption during breast cancer treatment. This factor is also expected to impact the growth of the segment positively.

Regional Outlooks:

The global breast lesion localization market is further segmented based on geography including North America (the US, and Canada), Europe (Italy, Spain, Germany, France, and Others), Asia-Pacific (India, China, Japan, South Korea, and Others), and the Rest of the World (the Middle East &Africa, and Latin America). The market can be analyzed for particular region or country level as per the requirement. Among these, the Asia-Pacific regional market is expected to hold significant share in the market growth over the forecast period owing to the factors such as market players are taking strategic initiatives on widening product portfolio, diversified business operations, lower costs, user satisfaction, and improve breast lesion localization Methods reliability.

The North America Region Is Expected To Hold Prominent Share in the Global Breast Lesion Localization Market

North America is expected to hold a prominent share in the market over the forecast period. The factors such as rising burden of breast cancer cases coupled with robust healthcare infrastructure and increasing awareness about breast cancer are propelling the growth of the breast lesion localization market. The rising breast cancer cases rise the demand for diagnostics and surgical procedures for treating breast cancer which will contribute to the breast lesion localization market over the years. Furthermore, the rising product approvals in the region increase the availability of localization devices in the market which is anticipated to boost market growth over the forecast period.

Market Players Outlook:

The major companies serving the global breast lesion localization market include Argon Medical Devices, Matek Medical Devices Technology Industry and Trade Inc., Sterylab S.R.L., Medax Medical Devices, and others. The market players are considerably contributing to the market growth by the adoption of various strategies including mergers and acquisitions, partnerships, collaborations, funding, and new product launches, to stay competitive in the market. For instance, in July 2022, Merit Medical System enrolled the first patient in a post-market, observational study to demonstrate the benefits of SCOUT, a wireless, radar-guided localization system for marking breast tumors, biopsy sites, and lymph nodes.

Table of Contents

1. Report Summary

  • Current Industry Analysis and Growth Potential Outlook
  • 1.1. Research Methods and Tools
  • 1.2. Market Breakdown
    • 1.2.1. By Segments
    • 1.2.2. By Region

2. Market Overview and Insights

  • 2.1. Scope of the Report
  • 2.2. Analyst Insight & Current Market Trends
    • 2.2.1. Key Findings
    • 2.2.2. Recommendations
    • 2.2.3. Conclusion

3. Competitive Landscape

  • 3.1. Key Company Analysis
    • 3.1.1. Overview
    • 3.1.2. Financial Analysis
    • 3.1.3. SWOT Analysis
    • 3.1.4. Recent Developments
  • 3.2. Key Strategy Analysis

4. Market Segmentation

  • 4.1. Global Breast Lesion Localization Market by Type
    • 4.1.1. Wire Localization
    • 4.1.2. Radioisotope Localization
    • 4.1.3. Magnetic Localization
    • 4.1.4. Electromagnetic Localization
    • 4.1.5. Other Localization
  • 4.2. Global Breast Lesion Localization Market by Usage
    • 4.2.1. Breast Biopsy
    • 4.2.2. Breast Conservation (Lumpectomy)
    • 4.2.3. Others

5. Regional Analysis

  • 5.1. North America
    • 5.1.1. United States
    • 5.1.2. Canada
  • 5.2. Europe
    • 5.2.1. UK
    • 5.2.2. Germany
    • 5.2.3. Italy
    • 5.2.4. Spain
    • 5.2.5. France
    • 5.2.6. Rest of Europe
  • 5.3. Asia-Pacific
    • 5.3.1. China
    • 5.3.2. India
    • 5.3.3. Japan
    • 5.3.4. South Korea
    • 5.3.5. Rest of Asia-Pacific
  • 5.4. Rest of the World

6. Company Profiles

  • 6.1. Argon Medical Devices
  • 6.2. Becton, Dickinson and Co.
  • 6.3. Biomedical S.R.L
  • 6.4. Biopsybell S.R.L.
  • 6.5. C.R. Bard, Inc.
  • 6.6. CP Medical
  • 6.7. Devicor Medical Products Inc.
  • 6.8. Endomagnetics Ltd.
  • 6.9. Hologic Inc.
  • 6.10. IsoAid
  • 6.11. Leica Biosystems Nussloch GmbH
  • 6.12. Matek Medical Devices Technology Industry and Trade Inc.
  • 6.13. MDL SRL
  • 6.14. Medax Medical Devices
  • 6.15. Merit Medical Systems, Inc.
  • 6.16. Mermaid Medical A/S
  • 6.17. Molli Surgical Inc.
  • 6.18. Ranfac Corp.
  • 6.19. Sirius Medical Systems B.V.
  • 6.20. Sterylab S.R.L.
  • 6.21. SurgicEye GmbH
  • 6.22. Tsunami Medical S.R.L.
  • 6.23. Vigeo S.R.L.

LIST OF TABLES

  • 1. GLOBAL BREAST LESION LOCALIZATION MARKET RESEARCH AND ANALYSIS BY TYPE, 2022-2030 ($ MILLION)
  • 2. GLOBAL WIRE BREAST LESION LOCALIZATION MARKET RESEARCH AND ANALYSIS BY REGION, 2022-2030 ($ MILLION)
  • 3. GLOBAL RADIOISOTOPE BREAST LESION LOCALIZATION MARKET RESEARCH AND ANALYSIS BY REGION, 2022-2030 ($ MILLION)
  • 4. GLOBAL MAGNETIC BREAST LESION LOCALIZATION MARKET RESEARCH AND ANALYSIS BY RE-GION, 2022-2030 ($ MILLION)
  • 5. GLOBAL ELECTROMAGNETIC BREAST LESION LOCALIZATION MARKET RESEARCH AND ANALYSIS BY REGION, 2022-2030 ($ MILLION)
  • 6. GLOBAL OTHER BREAST LESION LOCALIZATION MARKET RESEARCH AND ANALYSIS BY REGION, 2022-2030 ($ MILLION)
  • 7. GLOBAL BREAST LESION LOCALIZATION MARKET RESEARCH AND ANALYSIS BY USAGE, 2022-2030 ($ MILLION)
  • 8. GLOBAL BREAST BIOPSY LESION LOCALIZATION MARKET RESEARCH AND ANALYSIS BY REGION, 2022-2030 ($ MILLION)
  • 9. GLOBAL BREAST CONSERVATION LESION LOCALIZATION MARKET RESEARCH AND ANALYSIS BY REGION, 2022-2030 ($ MILLION)
  • 10. GLOBAL OTHER BREAST LESION LOCALIZATION MARKET RESEARCH AND ANALYSIS BY REGION, 2022-2030 ($ MILLION)
  • 11. GLOBAL BREAST LESION LOCALIZATION MARKET RESEARCH AND ANALYSIS BY REGION, 2022-2030 ($ MILLION)
  • 12. NORTH AMERICAN BREAST LESION LOCALIZATION MARKET RESEARCH AND ANALYSIS BY COUNTRY, 2022-2030 ($ MILLION)
  • 13. NORTH AMERICAN BREAST LESION LOCALIZATION MARKET RESEARCH AND ANALYSIS BY TYPE, 2022-2030 ($ MILLION)
  • 14. NORTH AMERICAN BREAST LESION LOCALIZATION MARKET RESEARCH AND ANALYSIS BY US-AGE, 2022-2030 ($ MILLION)
  • 15. EUROPEAN BREAST LESION LOCALIZATION MARKET RESEARCH AND ANALYSIS BY COUNTRY, 2022-2030 ($ MILLION)
  • 16. EUROPEAN BREAST LESION LOCALIZATION MARKET RESEARCH AND ANALYSIS BY TYPE, 2022-2030 ($ MILLION)
  • 17. EUROPEAN BREAST LESION LOCALIZATION MARKET RESEARCH AND ANALYSIS BY USAGE, 2022-2030 ($ MILLION)
  • 18. ASIA-PACIFIC BREAST LESION LOCALIZATION MARKET RESEARCH AND ANALYSIS BY COUNTRY, 2022-2030 ($ MILLION)
  • 19. ASIA-PACIFIC BREAST LESION LOCALIZATION MARKET RESEARCH AND ANALYSIS BY TYPE, 2022-2030 ($ MILLION)
  • 20. ASIA-PACIFIC BREAST LESION LOCALIZATION MARKET RESEARCH AND ANALYSIS BY USAGE, 2022-2030 ($ MILLION)
  • 21. REST OF THE WORLD BREAST LESION LOCALIZATION MARKET RESEARCH AND ANALYSIS BY COUNTRY, 2022-2030 ($ MILLION)
  • 22. REST OF THE WORLD BREAST LESION LOCALIZATION MARKET RESEARCH AND ANALYSIS BY TYPE, 2022-2030 ($ MILLION)
  • 23. REST OF THE WORLD BREAST LESION LOCALIZATION MARKET RESEARCH AND ANALYSIS BY US-AGE, 2022-2030 ($ MILLION)

LIST OF FIGURES

  • 1. GLOBAL BREAST LESION LOCALIZATION MARKET SHARE BY TYPE, 2022 VS 2030 (%)
  • 2. GLOBAL WIRE BREAST LESION LOCALIZATION MARKET SHARE BY REGION, 2022 VS 2030 (%)
  • 3. GLOBAL RADIOISOTOPE BREAST LESION LOCALIZATION MARKET SHARE BY REGION, 2022 VS 2030 (%)
  • 4. GLOBAL MAGNETIC BREAST LESION LOCALIZATION MARKET SHARE BY REGION, 2022 VS 2030 (%)
  • 5. GLOBAL ELECTROMAGNETIC BREAST LESION LOCALIZATION MARKET SHARE BY REGION, 2022 VS 2030 (%)
  • 6. GLOBAL OTHER BREAST LESION LOCALIZATION MARKET SHARE BY REGION, 2022 VS 2030 (%)
  • 7. GLOBAL BREAST LESION LOCALIZATION MARKET SHARE BY USAGE, 2022 VS 2030 (%)
  • 8. GLOBAL BREAST BIOPSY LESION LOCALIZATION MARKET SHARE BY REGION, 2022 VS 2030 (%)
  • 9. GLOBAL BREAST CONSERVATION LESION LOCALIZATION MARKET SHARE BY REGION, 2022 VS 2030 (%)
  • 10. GLOBAL OTHER BREAST LESION LOCALIZATION MARKET SHARE BY REGION, 2022 VS 2030 (%)
  • 11. GLOBAL BREAST LESION LOCALIZATION MARKET SHARE BY REGION, 2022 VS 2030 (%)
  • 12. US BREAST LESION LOCALIZATION MARKET SIZE, 2022-2030 ($ MILLION)
  • 13. CANADA BREAST LESION LOCALIZATION MARKET SIZE, 2022-2030 ($ MILLION)
  • 14. UK BREAST LESION LOCALIZATION MARKET SIZE, 2022-2030 ($ MILLION)
  • 15. FRANCE BREAST LESION LOCALIZATION MARKET SIZE, 2022-2030 ($ MILLION)
  • 16. GERMANY BREAST LESION LOCALIZATION MARKET SIZE, 2022-2030 ($ MILLION)
  • 17. ITALY BREAST LESION LOCALIZATION MARKET SIZE, 2022-2030 ($ MILLION)
  • 18. SPAIN BREAST LESION LOCALIZATION MARKET SIZE, 2022-2030 ($ MILLION)
  • 19. REST OF EUROPE BREAST LESION LOCALIZATION MARKET SIZE, 2022-2030 ($ MILLION)
  • 20. INDIA BREAST LESION LOCALIZATION MARKET SIZE, 2022-2030 ($ MILLION)
  • 21. CHINA BREAST LESION LOCALIZATION MARKET SIZE, 2022-2030 ($ MILLION)
  • 22. JAPAN BREAST LESION LOCALIZATION MARKET SIZE, 2022-2030 ($ MILLION)
  • 23. SOUTH KOREA BREAST LESION LOCALIZATION MARKET SIZE, 2022-2030 ($ MILLION)
  • 24. REST OF ASIA-PACIFIC BREAST LESION LOCALIZATION MARKET SIZE, 2022-2030 ($ MILLION)
  • 25. REST OF THE WORLD BREAST LESION LOCALIZATION MARKET SIZE, 2022-2030 ($ MILLION)